Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from the Alzheimer Association

FDA approves Leqembi, first drug to slow Alzheimer’s progression

Eisai and Biogen's Leqembi is the first drug to slow Alzheimer's progression to receive full FDA approval.

Axios

Expected Alzheimer’s drug approval signals new era in treatment - Roll Call

The Alzheimer's drug's approval would trigger broader access under Medicare, but critics say it shouldn't be on the market at all.

Roll Call

Does Medicare pay for Alzheimer's drugs? The answer is complicated and changing

There are no drugs or treatments to cure Alzheimer’s disease, but emerging drugs may slow disease progression.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA advisers say new Alzheimer’s drug lecanemab slows cognitive decline

Panel’s opinion could pave way for full regulatory approval next month for treatment of disease that affects 6.5m Americans

The Guardian - US

Experts' warning over common disorders that could actually be signs of dementia

Depression, sleep apnea and vitamin deficiency are just some of the disorders known as 'dementia mimickers' - illnesses that have symptoms very similar to dementia's

Daily Mirror

Dementia experts share tell-tale signs of disease as one labels disease 'time bomb' for ageing population

The awful disease, which can see patients forgetting their dearest family members, affects more than 850,000 people in the UK according to the NHS

Nottingham Post

Dementia experts reveal tell-tale signs of disease amid 'time bomb' population warning

Researchers say that improved life expectancy is leading to a rise in the number of people with Alzheimer's or another form of the disease.

Daily Record

Read news from The Economist, FT, and more,
with one subscription

Dementia experts reveal tell-tale signs of disease as one warns disease is 'time bomb' in US population

Over one in 10 adults in the US over the age of 65 have dementia. Although most patients have Alzheimer's there are other less common types including Frontotemporal dementia which Hollywood star Bruce Willis has been diagnosed with

Daily Mirror

A daily multivitamin to boost memory? Here's what to know

A new study shows a daily multivitamin may boost memory function in some people, although the results don't change recommendations about use of the supplements

The Independent UK

Commentary: By avoiding funding Alzheimer’s research, the government is cutting seniors’ life spans

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

Chicago Tribune

Why more Floridians are taking care of someone with dementia

TAMPA, Fla. -- They bonded over a shared love of small business and baseball games in their quiet Iowa town.

Tribune News Service

Alzheimer’s report hints at a future health crisis bigger than COVID-19

The costs of Alzheimer’s disease – human and financial – are rising sharply in California and nationally, and census projections for America’s rapidly aging population suggest the scope of the disease soon might rival what America saw during the height of the COVID-19 pandemic.

The Orange County Register

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

205 stories

Biogen

195 stories

the University of Chicago

89 stories

Eisai

79 stories

the Alzheimer Association

37 stories

Alzheimer Association

19 stories

Leqembi

18 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.